Single-dose Pharmacokinetic Study of Deferiprone Extended Release Tablets Versus Ferriprox Immediate Release Tablets Under Fasting and Fed Conditions in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2016
At a glance
- Drugs Deferiprone (Primary) ; Deferiprone
- Indications Iron overload; Pantothenate kinase-associated neurodegeneration
- Focus Pharmacokinetics
- Sponsors ApoPharma
- 21 Aug 2015 Status changed from active, no longer recruiting to completed as reported by clinicalTrials.gov.
- 09 Jul 2015 Status changed from not yet recruiting to active, no longer recruiting as reported by clinicalTrials.gov.
- 11 Jun 2015 New trial record